Where to Inject a GLP-1: Sites, Rotation, and the Rule That Differs by Drug

The short answer

All three of the common weekly injections go into fat just under the skin, and all three name the same general real estate: abdomen, thigh, upper arm. But the instructions are not identical across drugs, and one difference matters if you are injecting yourself.

The difference most roundups flatten

Read Zepbound's administration instruction closely. It says to inject in the abdomen or thigh, and that another person should inject in the back of the upper arm¹. Wegovy and Ozempic simply list the upper arm alongside the other two, with no such qualifier^2,3.

So if you are dosing yourself with no one around — which, for most working mothers, is the entire situation — Zepbound is effectively an abdomen-or-thigh drug. That is not a safety warning, and nothing terrible happens if you have been doing otherwise. It is a practical instruction that gets lost when articles merge all three drugs into one tidy line, and it is worth knowing before you plan your rotation around a site you cannot reliably reach.

If you have not settled on a drug yet, Zepbound vs Wegovy covers the rest of the differences, and the best GLP-1 for busy moms board scores which programs carry both molecules on one plan.

Does the site change how well it works?

No, and this is the useful part. Zepbound's clinical pharmacology section states that similar drug exposure was achieved whether it was injected into the abdomen, thigh or upper arm¹.

That reframes the question. You are not choosing a site to get more out of the dose — you are choosing for comfort, convenience and skin you can see. Some other numbers worth having from the same section: peak concentration arrives a median of 24 hours after injection, with a range of 8 to 72 hours, and about 80% of the dose reaches your bloodstream¹. The dose is not "in" within minutes, so injecting before a big day makes no difference either way.

How to actually rotate

• Pick a region for the week, then move within it. Abdomen one week, thigh the next is fine; so is staying in the abdomen and moving to a different spot. What every label rules out is hitting the same patch of skin dose after dose^1,2,3.
• Stay clear of the navel. Keep a couple of inches away, and avoid skin that is bruised, tender, hard, scarred or broken.
• Note the drug you are on. On Zepbound the upper arm is a two-person site, so build your rotation from the sites you can reach¹.
• Same day each week, any time of day. Both semaglutide labels state it explicitly, with or without meals — so pick the day that suits your week rather than a "best" time^2,3. If a dose step is what is making the week hard, hold, drop, or push through covers asking to delay it.
• Follow the Instructions for Use for your device. Vials, single-dose pens and KwikPens are handled differently, and the label routes technique to the leaflet for the presentation you were actually given¹. If your pharmacy switches you between them, you are entitled to fresh training.

If the site reacts

Redness, itching or a small lump at the injection site is common and usually settles — GLP-1 itching and rash sorts site irritation from the kinds of reaction that need a call. One detail from Zepbound's data is worth knowing: injection site reactions were reported in 11.3% of people who developed anti-tirzepatide antibodies, against 1% of those who did not¹. That is a real difference, and it means persistent, repeated site reactions are a reasonable thing to mention to your prescriber rather than something you simply put up with.

Anything that spreads, blisters, or comes with breathing difficulty or facial swelling is not a site reaction and needs urgent attention — not a rotation change.